Loading stock data…
INSP
$56.70+0.56 (+1.00%)
Market ClosedLast close May 1
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Inspire Medical Systems, Inc. in the Healthcare sector is trading at $56.70. The stock is currently near its 52-week low of $48.30, remaining 31.9% below its 200-day moving average. Technical signals show neutral RSI of 55 and bullish MACD crossover, explaining why INSP maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 55) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$56.70
Potential Upside
68%
Whystock Fair Value$95.26
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Buy
Mean target$72.25+27.4%
Range$56.00 – $120.00
Fundamentals
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.62B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.52
Beta
Defensive asset. Lower volatility than the S&P 500.
0.86
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.80%
Volume
Today's trading volume
952,581
Recent News
Is Inspire Medical Systems (INSP) Pricing In A Turnaround After A 66% One Year Slide?
If you are asking whether Inspire Medical Systems at US$53.41 is now priced for a recovery story or still carries too much risk, the starting point is to understand what the current market value really reflects. The stock has seen a 6.0% gain over the past 30 days, but that sits against a 42.1% decline year to date and a 66.3% decline over the last year. This naturally raises questions about how sentiment and risk perceptions have shifted. Recent coverage has focused on the company as part...
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of 0.00% and +2.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Tempus (TEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1
We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Inspire Medical Systems, Inc. is among the most undervalued stocks to invest in. TheFly reported on April 15 that Truist Financial reduced its price target for INSP from $70 to $64 while maintaining a Hold stance on the stock. The […]